The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions
Sign Up to like & getrecommendations! Published in 2019 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-019-0638-1
Abstract: Opinion statementFor the practicing clinician, the dilemma becomes how most appropriate to sequence the aforementioned regimens. It is challenging to be dogmatic, as there are no comparative studies juxtaposing novel front-line options directly—all of the… read more here.
Keywords: treatment; disease; risk disease; good risk ... See more keywords
Abstract P6-16-02: Cost-effectiveness of endocrine therapy or radiation treatment alone or in combination for standard- and good-risk DCIS
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p6-16-02
Abstract: Introduction: Ductal carcinoma in situ (DCIS) accounts for 20% of breast cancer cases in the United States and is potentially overtreated leading to high expenditures and low-value care. We conducted a first-of-its-kind cost-effectiveness analysis evaluating… read more here.
Keywords: risk; risk dcis; treatment; good risk ... See more keywords